MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

GoodRx Holdings Stock

GoodRx Holdings, Inc.

GDRXNASDAQMarkt
US$3.36
-4.1% today

Company data

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
United States
CEO
Wendy Barnes
Employees
697
Market cap
$1.1 B
IPO
23/09/2020

GoodRx Holdings, Inc. is a healthcare company operating within the medical, healthcare information services industry. Headquartered in Santa Monica, USA, the company was founded in 2015. The firm provides American consumers with essential resources and tools to compare and ultimately lower the cost of their…

Company description based on the data provider's company data, AI-assisted, created on 17/10/2026. Not investment advice.

GoodRx Holdings stock: price history

16/10/25-13.8 %16/10/26

1D

-4.3%

1W

-2.0%

1M

-0.9%

6M

+48.0%

YTD

+24.0%

1Y

-13.8%

2Y

-51.4%

5Y

-92.1%

10Y

–

Next earnings date

Next earnings date

03/11/2026 (in 17 days)

Volatility around earnings

~114% stronger price swings than usual

Ask the agents about GoodRx Holdings

Analyst assessment of GoodRx Holdings

PRICE TARGET LOW

US$3.75

CONSENSUS

US$4.19

MEDIAN

US$4.00

PRICE TARGET HIGH

US$5.00

0

STRONG BUY

9

BUY

13

HOLD

2

SELL

0

STRONG SELL

24

TOTAL · Hold

As of: 21/08/2026

ANALYST FIRMRATINGACTIONDATE
BarclaysUnderweightmaintain21/08/2026
UBSNeutralmaintain13/08/2026
TD CowenBuymaintain11/08/2026
CitigroupBuymaintain11/08/2026
Wells FargoOverweightmaintain07/08/2026
CitigroupBuymaintain14/05/2026
TD CowenBuymaintain11/05/2026
Wells FargoOverweightmaintain04/03/2026

GoodRx Holdings stock metrics

P/E

63.88

P/B

1.76

EV/EBITDA

8.13

RETURN ON EQUITY

1.3%

NET MARGIN

4.3%

DEBT/EQUITY

0.83

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

82.4%

FLOAT SHARES

280,939,721

AVG. DAILY VOLUME (30D)

853,887

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Chan Thomas (TC)

OfficerOption exercise5,793–Spontaneous15/10/2026

Barnes Wendy Lynn

OfficerTax settlement48,2033.38Spontaneous15/10/2026

Barnes Wendy Lynn

OfficerOption exercise110,963–Spontaneous15/10/2026

Barnes Wendy Lynn

OfficerTax settlement22,2323.38Spontaneous15/10/2026

Barnes Wendy Lynn

OfficerOption exercise51,177–Spontaneous15/10/2026
Page 1 / 17

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Ronald Blue Trust, Inc.0-2530/09/2026
WOODSTOCK CORP0-102,02930/09/2026
Francisco Partners Management, LP60,078,184+030/06/2026
LSV ASSET MANAGEMENT5,156,711+174,78030/06/2026
AMERIPRISE FINANCIAL INC4,746,330+290,57030/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about GoodRx Holdings stock

What does GoodRx Holdings do?

GoodRx Holdings, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.

The CEO is Wendy Barnes, the company employs around 697 people.

The IPO was on 23/09/2020; the stock trades on NASDAQ under the ticker GDRX.

What do analysts say about GoodRx Holdings stock?

24 analysts rate the stock, the consensus is Hold (as of 21/08/2026).

The average price target is US$4.19, ranging from US$3.75 to US$5.00, with a median of US$4.00.

This is an external assessment, not a statement by Market Jury.

When does GoodRx Holdings report next?

The next earnings date is 03/11/2026.

Around past earnings, price swings were roughly 114% stronger than usual.

Does GoodRx Holdings pay a dividend?

No, GoodRx Holdings currently does not pay a dividend.

Which stocks are comparable to GoodRx Holdings?

Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.

How can I get GoodRx Holdings stock analyzed?

Clicking "Analyze stock" lets five strategies assess GoodRx Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.